Powder: -20°C for 3 years | In solvent: -80°C for 1 year
N-desmethyl Rosiglitazone is a major metabolite of rosiglitazone , a potent and selective PPARγ ligand present in formulations that have been used to treat type 2 diabetes. Rosiglitazone is metabolized by the cytochrome P450 (CYP) isoform CYP2C8 to form N-desmethyl rosiglitazone.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 35 days | $ 988.00 |
Description | N-desmethyl Rosiglitazone is a major metabolite of rosiglitazone , a potent and selective PPARγ ligand present in formulations that have been used to treat type 2 diabetes. Rosiglitazone is metabolized by the cytochrome P450 (CYP) isoform CYP2C8 to form N-desmethyl rosiglitazone. |
Molecular Weight | 343.4 |
Formula | C17H17N3O3S |
CAS No. | 257892-31-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO:PBS(pH 7.2) (1:3): 0.5 mg/mL
DMSO: 34 mg/mL
DMF: 25 mg/mL
Ethanol: 1 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
N-desmethyl Rosiglitazone 257892-31-2 N desmethyl Rosiglitazone Ndesmethyl Rosiglitazone inhibitor inhibit